Jesse Dovich, MD, Wins Tesla at 2017 ASCRS Meeting

May 8, 2017: By Market Scope
Jesse Dovich, MD (right), winner of the Tesla at the 2017 ASCRS meeting.

Jesse Dovich, MD (right), winner of the Tesla at the 2017 ASCRS meeting. (Photo by Katie Cannady)

 

Ophthalmologist Jesse Dovich, MD, of Upland, California, was the winner of this year’s drawing for a Tesla electric car at the ASCRS annual meeting in Los Angeles.

The drawing was held May 8 at the ASCRS Exhibit Hall.

Dovich won a 2017 sapphire blue Model S.

He practices at the Pacific Eye Institute and Laser Center, with several locations in California, and is a clinical instructor with the Department of Ophthalmology at Loma Linda University.

In 2015, Thomas Carter, MD, of Ponca City, OK, won the ASCRS’ initial drawing for a 2015 red Tesla Model S at the meeting in San Diego.

In 2016, David Russell Brear, MD, of Culpeper, VA, was the winner of a blue Tesla Model S at the annual meeting in New Orleans.

This year’s drawing was available to conference attendees who obtained specially numbered tickets from exhibitors or ASCRS officials.

Attendees also could gain a ticket by contributing to the ASCRS Foundation or completing the ASCRS clinical survey.

Dovich’s ticket was the first one drawn.

 

A crowd forms May 8 at the Exhibit Hall for the drawing of a Tesla Model S at the 2017 ASCRS meeting in Los Angeles.

A crowd forms May 8 at the Exhibit Hall for the drawing of a Tesla Model S at the 2017 ASCRS meeting in Los Angeles. (Photo by Tony Ingenito)

 

Tesla winner Jesse Dovich after the drawing

Tesla winner Jesse Dovich, MD, after the drawing. (Photo by Katie Cannady)

Need Deeper Analysis? Sign up for Market Scope's monthly newsletter to get in-depth coverage of the ophthalmic market, including quarterly procedure volumes based on survey data and meeting coverage from around the world.

Recent Ophthalmic News

Quidel Acquires RPS’ InflammaDry, AdenoPlus Ophthalmic Diagnostic Tests

Gottlieb Says US FDA Can Help Reduce Drug Prices through Generics, Biosimilars

ONL Therapeutics Closes $4.25 Million Series A Financing

Omeros’ Omidria Revenues Total $12.3 Million in Q1-2017

Finland Eye Care Provider Silmäasema Oyj Plans IPO to Raise €35 Million

Alcon Introduces SYSTANE ICAPS Chewable Eye Vitamin

Aerie’s Rhopressa Gets Target Action Date from US FDA

STAAR’s EVO+ Visian ICL with Aspheric (EDOF) Optic Receives CE Mark Approval

Refocus to File for US Approval of VisAbility for Presbyopia in Q3-2017

Trial for James Mazzo Ends in Hung Jury; Co-defendants DeCinces, Parker Convicted

Alcon Names Stephen S. Lane, MD, as Chief Medical Officer

Allergan’s Restasis Sales Increase 3.4 Percent in Q1-2017

Ophtec Secures CE Marking for Aspheric Presbyopia-Correcting IOL

LENSAR Becomes Subsidiary of PDL, Gains FDA Clearance for Laser Integration with Pentacam, Aladdin

Bausch + Lomb Posts Q1-2017 Revenues of $1.15 Billion in ‘Solid Quarter’

Carl Zeiss Meditec’s Revenues Grow 8.6 percent in First Half of Fiscal Year

Hoya’s Reports Strong IOL Sales in Fiscal 2017 Fourth Quarter

Shire Licenses Parion’s P-321 for Dry Eye Disease

Imprimis’ Ophthalmic Sales Grow 105 Percent in Q1-2017

Bernie Haffey Named Chief Commercial Officer at SightLife Surgical

Coming soon

2017 Ophthalmic Laser Report: A Global Market Analysis for 2016 to 2022 (Photocoagulation, Photodisruption, and SLT)